Results 281 to 290 of about 2,872,365 (306)

Long-acting injectable buprenorphine – ‘best practice’ opioid agonist therapy for Australian prisoners

Australasian Psychiatry, 2021
Objective To consider opioid agonist therapy in prisons. Conclusions Given the substantial risks of substance misuse by prisoners, long-acting injectable buprenorphine should be adopted as ‘best practice’ treatment in Australian prison populations.
S. Russ, Aboud Andrew, O'Gorman Thomas
semanticscholar   +1 more source

Supervised Tablet Injectable Opioid Agonist Therapy (TiOAT): A Strategy to Address Safer Supply for Individuals With an Opioid Use Disorder?

Journal of addiction medicine, 2021
North America is in the midst of an overdose crisis, with up to 130 Americans dying daily from a preventable drug overdose. Opioids account for 70% of overdose deaths.
Jian-Cheng Weng, N. Fairbairn, Christy Sutherland, Cheyenne Johnson, S. Nolan   +4 more
semanticscholar   +1 more source

Managing Opioid Agonist Therapy in the Post-Soviet Limbo

Contemporary Drug Problems, 2021
According to Dante, “Limbo” is the first circle of Hell located at its edge. Unlike other residents of Hell, the Limbo population suffers no torment other than their lack of hope. We argue that a lack of hope in post-Soviet Ukraine is expressed by a lack of conditions for a better future since the past is overrepresented in the present.
Alexandra Dmitrieva, Vladimir Stepanov, Alyona Mazhnaya   +2 more
openaire   +1 more source

Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada [PDF]

Drug and Alcohol Dependence, 2018
Inability to access opioid agonist therapy (OAT) in correctional settings has previously been reported in Vancouver, Canada, and is associated with harms among people with opioid use disorder (OUD), including overdose death. We investigated the prevalence and correlates of OAT utilization within correctional settings among incarcerated persons with OUD
Evan Wood, Nikki Bozinoff, Nadia Fairbairn   +2 more
exaly   +3 more sources

Psychotherapeutic Benefits of Opioid Agonist Therapy

Journal of Addictive Diseases, 2008
Opioids have been used for centuries to treat a variety of psychiatric conditions with much success. The so-called "opium cure" lost popularity in the early 1950s with the development of non-addictive tricyclic antidepressants and monoamine oxidase inhibitors. Nonetheless, recent literature supports the potent role of methadone, buprenorphine, tramadol,
openaire   +2 more sources

[Opioid Agonist Therapy (OAT) for opioid dependency].

Therapeutische Umschau. Revue therapeutique, 2020
Opioid Agonist Therapy (OAT) for opioid dependency Abstract. The process of evaluating the necessity of an Opioid Agonist Therapy (OAT) is relatively simple. Once the criteria for an opioid dependency according to the ICD-10 (or DSM V) are met, treatment should be offered. Adequate individual dosing of the opioid agonist is crucial to treatment success.
Patrick, Köck, Johannes, Strasser
openaire   +1 more source

Posttraumatic stress disorder in opioid agonist therapy: A review.

Psychological Trauma: Theory, Research, Practice, and Policy, 2018
Posttraumatic stress disorder (PTSD) and opioid use disorder (OUD) co-occur at high rates, and this co-occurrence is associated with a range of problems related to mental and physical health. OUD is commonly treated with opioid agonist therapies (OAT), which have been shown to be effective for reducing opiate use and related negative health ...
Anthony H, Ecker, Natalie, Hundt
openaire   +2 more sources

Combatting the Opioid Crisis From Prison: Initiating Opioid Agonist Therapy

Journal of Forensic Nursing, 2018
ABSTRACT Presented is a case report of a young man dependent on fentanyl who did not receive opioid agonist therapy (OAT) during incarceration. Highlighted are the barriers to accessing OAT in custody, which exacerbates problems with drug-seeking behavior, diversion, and recidivism.
openaire   +2 more sources

Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids

Drug and Alcohol Review
ABSTRACT Introduction Opioid agonist therapies (OAT) reduce adverse outcomes of illicit opioid use, with individual preferences potentially improving treatment outcomes. We explored preferences for OAT and associated factors in a national sample of people with opioid dependence.
M. J. Stowe, Anna Conway, Frederick L. Altice, Samantha Colledge‐Frisby, Phillip Read, Mark Montebello, Gilbert Whitton, Jeremy Hayllar, Mark Daglish, Victoria Cock, Michael Christmass, Sione Crawford, Charles Henderson, Gregory J. Dore, Chris Gough, Michael Farrell, Louisa Degenhardt, Jason Grebely   +17 more
openaire   +4 more sources

Opioid Agonist Therapy for Fentanyl-Related Opioid Use Disorder: A Systematic Review

Journal of Addiction Medicine
Objectives: While treatment guidelines for opioid use disorder (OUD) are well-established, specific guidance for people who use fentanyl remains limited. This systematic review is the first to examine effectiveness and safety outcomes associated with opioid agonist therapy (OAT), specifically buprenorphine ...
Austin Daniel Solak, Jack Boynton, Jacob Riches, Allison Souter, Kathryn Dong, Maryam Zaree, Nicolas Woods, Alla Iansavitchene, Christopher Byrne   +8 more
openaire   +2 more sources